ArticleACS applied materials & interfaces2025
Long-Gap Sciatic Nerve Regeneration Using 3D-Printed Nerve Conduits with Controlled FGF-2 Release.
Article in ACS applied materials & interfaces, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Manufacturing, Cell Regulation, and Coculture Strategies for Vascularization and Neural Innervation of Skeletal Muscle Tissue.Advanced healthcare materials · 2026Review
- Synergistic Enhancement of Facial Nerve Regeneration Using a Cellulose-Based Nerve Conduit Loaded with Mesenchymal Stem Cells and Human Placental Extract.Bioengineering (Basel, Switzerland) · 2026Article
- Gelatin-Based Multifunctional Hydrogels for Sports Injury Repair: Musculoskeletal and Nervous System Perspectives.Gels (Basel, Switzerland) · 2026Review
- Three-Dimensional Printing of the Epineurium for Peripheral Nerve Repair: A Comprehensive Review of Novel Scaffolds for Nerve Conduits.Biomimetics (Basel, Switzerland) · 2026Review
- Contemporary Strategies of Gene and Cell Therapy in the Treatment of Peripheral Nervous System Injuries and Disorders.International journal of molecular sciences · 2026Review
- Regenerative medicine approaches for the treatment of peripheral nerve injuries: progress and challenges.Regenerative biomaterials · 2026Review
- Biphasic Electrical Stimulation of Schwann Cells on Conducting Polymer-Coated Carbon Microfibers.International journal of molecular sciences · 2025Article
- Advances in adhesion interfaces of peripheral nerve repair materials: mechanism, classification, evaluation method, and functionalization.Frontiers in cell and developmental biology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Peripheral nerve injuries (PNIs) by transection require reconstructive surgery, often with highly variable results and persistent sensory and motor deficits. Three-dimensional (3D) printing enables the biofabrication of nerve guidance conduits (NGCs) with the ability to release neurotrophic factors, showing therapeutic potential. We developed a 3D printing process of NGCs using polycaprolactone (PCL) and gelatin methacryloyl (GelMA) integrated with a thermostable fibroblast growth factor 2 (FGF-2). The synthesized GelMA at 10% (w/v) concentration showed superior rheological, mechanical, and ultrastructural characteristics, ensuring 3D printing fidelity. Incorporating FGF-2 into GelMA resulted in a controlled release pattern over 30 days along with biocompatibility and an increase of metabolism in rat S16 Schwann cells and human mesenchymal stem cells (MSCs). MSCs exhibited gene regulation linked to vascularization after FGF-2 stimulation. The PCL polymer facilitated the buildability of a spiral-patterned tubular structure, which was functionalized with a combination of GelMA and UV photocrosslinked. At 12 weeks, following a long-gap nerve injury in rats, NGC implantation enhanced sensory and motor recovery, improved electrophysiological function, and promoted morphological and ultrastructural nerve reorganization and regeneration. At 4 weeks, significant Schwann cell proliferation (S100), expression of the pan-neurotrophin receptor (P75NTR), myelination of newly grown axons, and organization of neurofilaments were observed. The bioactive NGCs represent a promising alternative to nerve autografts for the repair of long-gap injuries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.